Loading clinical trials...
Loading clinical trials...
The purpose of this trial is to identify a dose or doses of INS50589 intravenous infusion that are well-tolerated and which reduce postoperative bleeding and blood product transfusion.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Merck Sharp & Dohme LLC
NCT06273293 · Coronary Disease
NCT05599061 · Coronary Artery Disease, Coronary Disease, and more
NCT06535568 · Coronary Disease, Heart Diseases, and more
NCT05853419 · Coronary Disease
NCT07094737 · Cardiac Rehab, Heart Failure, and more
Baptist Medical Center Princeton
Birmingham, Alabama
Cardiology, P.C.
Birmingham, Alabama
Sharp Memorial Hospital
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions